BRCA2 and breast cancer: In contrast to the detection of a causal germline alteration in the other main breast cancer genes such as BRCA1, BRCA2 or PALB2, identification of a germline disease-causing TP53 variant in a patient with breast cancer may have an impact in her children under 18 years of age.